ストックスクリーナーアプリを入手
61.36
5.69%
-3.70
アフターアワーズ：
61.36
前日終値:
$65.06
開ける：
$60
24時間の取引高:
4.70M
Relative Volume:
1.95
時価総額：
$7.65B
収益：
$692.26M
当期純損益:
$-512.41M
株価収益率:
-14.47
EPS:
-4.24
ネットキャッシュフロー:
$-274.36M
1週間 パフォーマンス:
-4.82%
1か月 パフォーマンス:
+38.85%
6か月 パフォーマンス:
+47.93%
1年 パフォーマンス:
+151.99%
1日の値動き範囲:
$57.50
$61.48
1週間の範囲:
$57.50
$68.00
52週間の値動き範囲:
$20.14
$68.00
Guardant Health Inc Stock (GH) Company Profile
GH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
61.36 | 8.29B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
489.49 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
199.03 | 145.92B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
640.44 | 51.16B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
128.48 | 35.50B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
184.08 | 31.24B | 15.70B | 1.24B | 2.01B | 6.91 |
Guardant Health Inc Stock (GH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-10 | 開始されました | Mizuho | Outperform |
| 2025-01-23 | 開始されました | Barclays | Overweight |
| 2024-06-28 | アップグレード | Guggenheim | Neutral → Buy |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-24 | 再開されました | Craig Hallum | Buy |
| 2023-12-14 | 開始されました | Guggenheim | Neutral |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-11-13 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-09-27 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-26 | アップグレード | Citigroup | Neutral → Buy |
| 2023-05-05 | 開始されました | UBS | Buy |
| 2023-03-09 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2022-11-01 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | 開始されました | Craig Hallum | Buy |
| 2022-10-06 | 開始されました | Stephens | Overweight |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-06-03 | 開始されました | Piper Sandler | Overweight |
| 2022-04-28 | 再開されました | BTIG Research | Buy |
| 2022-02-24 | 繰り返されました | Canaccord Genuity | Buy |
| 2022-02-24 | 繰り返されました | Citigroup | Buy |
| 2022-02-24 | 繰り返されました | Cowen | Outperform |
| 2022-02-24 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-02-24 | 繰り返されました | SVB Leerink | Outperform |
| 2022-02-24 | 繰り返されました | Stifel | Buy |
| 2022-02-24 | 繰り返されました | Wells Fargo | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-15 | 開始されました | Raymond James | Mkt Perform |
| 2021-06-03 | 開始されました | Goldman | Buy |
| 2021-05-25 | 開始されました | Wells Fargo | Overweight |
| 2021-01-11 | 開始されました | Stifel | Buy |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-06-12 | 開始されました | BTIG Research | Buy |
| 2020-02-21 | 開始されました | Guggenheim | Buy |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-08-07 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-04-16 | 開始されました | Canaccord Genuity | Buy |
| 2019-04-10 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | 繰り返されました | BofA/Merrill | Neutral |
| 2018-10-29 | 開始されました | BofA/Merrill | Neutral |
| 2018-10-29 | 開始されました | JP Morgan | Overweight |
| 2018-10-29 | 開始されました | William Blair | Outperform |
すべてを表示
Guardant Health Inc (GH) 最新ニュース
Liquid Biopsy in Cancer Diagnostics Market to Witness Robust ~17% CAGR Expansion by 2032 | DelveInsight - Barchart.com
Is Guardant Health Inc. stock ready for a breakoutPortfolio Performance Summary & Stepwise Trade Execution Plans - Newser
Analyzing recovery setups for Guardant Health Inc. investors2025 Top Gainers & Risk Managed Trade Strategies - Newser
How to recover losses in Guardant Health Inc. stockPortfolio Update Summary & Stepwise Swing Trade Plans - Newser
Multi asset correlation models including Guardant Health Inc.Options Play & Daily Profit Focused Stock Screening - Newser
Is Guardant Health Inc. showing signs of accumulationEarnings Summary Report & Entry Point Confirmation Alerts - Newser
Guardant Health Inc. stock daily chart insightsPortfolio Profit Report & Safe Capital Growth Tips - Newser
Is It Too Late to Sell Guardant Health Inc.2025 Big Picture & Daily Technical Forecast Reports - beatles.ru
Automated trading signals detected on Guardant Health Inc.Weekly Gains Report & Capital Efficiency Focused Strategies - Newser
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands - PR Newswire
Will Guardant Health Inc. stock split in the near futureMarket Weekly Review & Weekly Momentum Picks - Newser
Is GH's Q1 2025 forecast achievable? - AInvest
Advanced analytics toolkit walkthrough for Guardant Health Inc.Analyst Downgrade & Weekly Top Gainers Alerts - Newser
Cyted Health’s $44M Series B: A Strategic Bet on Early Cancer Detection and Global Expansion - AInvest
Liquid Biopsy Market Trends and Industry Forecast to 2030 - GlobeNewswire
Liquid Biopsy Market Trends and Industry Forecast to 2030 Featuring Strategic Analysis of Natera, Guardant Health, Myriad Genetics, Illumina, and Roche Among Others - Yahoo Finance
Will Guardant Health Inc. see short term momentumTrade Volume Summary & Growth Focused Stock Reports - Newser
What’s the analyst consensus on Guardant Health Inc.Rate Cut & Free Real-Time Market Sentiment Alerts - خودرو بانک
How to read the order book for Guardant Health Inc.Market Growth Report & Risk Managed Investment Entry Signals - Newser
Is Guardant Health Inc. impacted by rising ratesQuarterly Profit Review & Smart Money Movement Alerts - khodrobank.com
Will Guardant Health Inc. bounce back from current supportJuly 2025 PreEarnings & Intraday High Probability Setup Alerts - Newser
What to do if you’re stuck in Guardant Health Inc.Portfolio Growth Summary & Capital Efficiency Focused Ideas - Newser
Live market analysis of Guardant Health Inc.Dividend Hike & Stepwise Swing Trade Plans - Newser
Signal strength of Guardant Health Inc. stock in tech scannersJuly 2025 Market Mood & High Yield Stock Recommendations - Newser
Guardant Health Inc. stock prediction for this weekTreasury Yields & Technical Analysis for Trade Confirmation - Newser
Using flow based indicators on Guardant Health Inc.Weekly Trend Summary & Risk Controlled Stock Pick Alerts - Newser
Will Guardant Health Inc. Bounce From 52 Week Low getLinesFromResByArray error: size == 0 - 더경남뉴스
Guardant Health Inc. stock outlook for YEARForecast Cut & Expert Curated Trade Setup Alerts - Newser
Will Guardant Health Inc. stock recover after recent drop2025 Support & Resistance & Long-Term Growth Stock Strategies - Newser
Guardant Health’s Strategic Moves and Analyst Confidence Propel Market Potential - StocksToTrade
Technical signs of recovery in Guardant Health Inc.2025 Retail Activity & Low Drawdown Trading Techniques - Newser
Can machine learning forecast Guardant Health Inc. recoveryEarnings Summary Report & Reliable Intraday Trade Alerts - Newser
Backtesting results for Guardant Health Inc. trading strategiesPortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - Newser
Is Guardant Health Inc. stock showing strong momentumWeekly Trading Summary & Expert Approved Trade Ideas - sundaytimes.kr
Guardant Health Inc (GH) 財務データ
収益
当期純利益
現金流量
EPS
Guardant Health Inc (GH) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Saia John G. | Chief Legal Officer |
Sep 01 '25 |
Option Exercise |
0.00 |
264 |
0 |
45,087 |
| Kalia Kumud | Chief Information Officer |
Sep 01 '25 |
Option Exercise |
0.00 |
711 |
0 |
19,211 |
| Chudova Darya | Chief Technology Officer |
Sep 01 '25 |
Option Exercise |
0.00 |
316 |
0 |
81,610 |
| Krognes Steve E. | Director |
Aug 31 '25 |
Option Exercise |
0.00 |
155 |
0 |
18,128 |
3.32%
0.58%
大文字化:
|
ボリューム (24 時間):